These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 16969696
1. Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS. Shah LK, Amiji MM. Pharm Res; 2006 Nov; 23(11):2638-45. PubMed ID: 16969696 [Abstract] [Full Text] [Related]
2. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Shenoy DB, Amiji MM. Int J Pharm; 2005 Apr 11; 293(1-2):261-70. PubMed ID: 15778064 [Abstract] [Full Text] [Related]
3. A model predicting delivery of saquinavir in nanoparticles to human monocyte/macrophage (Mo/Mac) cells. Ece Gamsiz D, Shah LK, Devalapally H, Amiji MM, Carrier RL. Biotechnol Bioeng; 2008 Dec 01; 101(5):1072-82. PubMed ID: 18553495 [Abstract] [Full Text] [Related]
4. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model. Devalapally H, Shenoy D, Little S, Langer R, Amiji M. Cancer Chemother Pharmacol; 2007 Mar 01; 59(4):477-84. PubMed ID: 16862429 [Abstract] [Full Text] [Related]
5. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations. Shenoy D, Little S, Langer R, Amiji M. Mol Pharm; 2005 Mar 01; 2(5):357-66. PubMed ID: 16196488 [Abstract] [Full Text] [Related]
6. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery. Potineni A, Lynn DM, Langer R, Amiji MM. J Control Release; 2003 Jan 17; 86(2-3):223-34. PubMed ID: 12526819 [Abstract] [Full Text] [Related]
7. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma. Feng N, Wu P, Li Q, Mei Y, Shi S, Yu J, Xu J, Liu Y, Wang Y. J Drug Target; 2008 Jul 17; 16(6):479-85. PubMed ID: 18604660 [Abstract] [Full Text] [Related]
8. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies. Shenoy D, Little S, Langer R, Amiji M. Pharm Res; 2005 Dec 17; 22(12):2107-14. PubMed ID: 16254763 [Abstract] [Full Text] [Related]
9. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells. Xiong XB, Mahmud A, Uludağ H, Lavasanifar A. Biomacromolecules; 2007 Mar 17; 8(3):874-84. PubMed ID: 17315946 [Abstract] [Full Text] [Related]
10. Enhancement in anti-proliferative effects of paclitaxel in aortic smooth muscle cells upon co-administration with ceramide using biodegradable polymeric nanoparticles. Deshpande D, Devalapally H, Amiji M. Pharm Res; 2008 Aug 17; 25(8):1936-47. PubMed ID: 18480968 [Abstract] [Full Text] [Related]
11. Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles. Devalapally H, Duan Z, Seiden MV, Amiji MM. Clin Cancer Res; 2008 May 15; 14(10):3193-203. PubMed ID: 18483388 [Abstract] [Full Text] [Related]
12. Monolayer-protected gold nanoparticles by the self-assembly of micellar poly(ethylene oxide)-b-poly(epsilon-caprolactone) block copolymer. Azzam T, Eisenberg A. Langmuir; 2007 Feb 13; 23(4):2126-32. PubMed ID: 17279704 [Abstract] [Full Text] [Related]
13. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection. Jang JS, Kim SY, Lee SB, Kim KO, Han JS, Lee YM. J Control Release; 2006 Jun 28; 113(2):173-82. PubMed ID: 16750279 [Abstract] [Full Text] [Related]
14. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity. Singh R, Kesharwani P, Mehra NK, Singh S, Banerjee S, Jain NK. Drug Dev Ind Pharm; 2015 Jun 28; 41(11):1888-901. PubMed ID: 25738812 [Abstract] [Full Text] [Related]
15. Design and evaluation of D-α tocopheryl polyethylene glycol 1000 succinate emulsified poly-ϵ-caprolactone nanoparticles for protein/peptide drug delivery. Rayaprolu BM, Strom JG. Drug Dev Ind Pharm; 2013 Jul 28; 39(7):1046-52. PubMed ID: 22758209 [Abstract] [Full Text] [Related]
16. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors. Molavi O, Ma Z, Mahmud A, Alshamsan A, Samuel J, Lai R, Kwon GS, Lavasanifar A. Int J Pharm; 2008 Jan 22; 347(1-2):118-27. PubMed ID: 17681440 [Abstract] [Full Text] [Related]
17. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro. Gou M, Zheng L, Peng X, Men K, Zheng X, Zeng S, Guo G, Luo F, Zhao X, Chen L, Wei Y, Qian Z. Int J Pharm; 2009 Jun 22; 375(1-2):170-6. PubMed ID: 19427143 [Abstract] [Full Text] [Related]
18. Enhancement of cellular uptake, transport and oral absorption of protease inhibitor saquinavir by nanocrystal formulation. He Y, Xia DN, Li QX, Tao JS, Gan Y, Wang C. Acta Pharmacol Sin; 2015 Sep 22; 36(9):1151-60. PubMed ID: 26256404 [Abstract] [Full Text] [Related]
20. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery. Shahin M, Lavasanifar A. Int J Pharm; 2010 Apr 15; 389(1-2):213-22. PubMed ID: 20080163 [Abstract] [Full Text] [Related] Page: [Next] [New Search]